BlackRock Private Credit Fund
BlackRock Private Credit Fund issued 245,505.01 Institutional Class Shares for $5,778,304 to feeder vehicles in an unregistered private placement exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →Filings Radar
SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Addex Therapeutics Ltd. (ADXN)
Addex announced the sale of 437,869 ADSs (representing 52,544,280 shares) for USD 2.8 million through an At the Market (ATM) offering agreement with H.C. Wainwright & Co. This is an unregistered equity issuance that dilutes existing shareholders. The disclosure explicitly states the outstanding shares increased to 210,292,217 shares, confirming material dilution. ATM offerings are a classic signal of capital-raising pressure at small- and mid-cap issuers.
View raw filing on EDGAR →Optimi Health Corp. (OPTHF)
Optimi Health entered into an equity line of credit (ELOC) with Seven Knots, LLC on August 13, 2026, granting the Company the right to sell up to US$100 million of common shares over the facility's term. The Company also issued convertible promissory notes (US$1.5 million initially, potentially US$500,000 more) convertible into common shares at 95% of the 20-day VWAP with a US$3.00 floor. This is a dilutive equity issuance arrangement that provides the Company with capital-raising flexibility while creating significant shareholder dilution risk, particularly given the convertible notes' favorable conversion terms and the ELOC's discretionary draw structure.
View raw filing on EDGAR →Neo-Concept International Group Holdings Ltd (NCI)
The Company issued 140,000 Class B Ordinary Shares to CEO/Chairman Pengfei Jiang at par value (US$350 total), which immediately grants him approximately 64.0% of aggregate voting power through a super-voting structure (30 votes per Class B share vs. 1 vote per Class A share). While the dollar amount is nominal, the dilutive effect and control concentration are material to investors assessing governance and ownership structure. This is a related-party equity issuance that materially shifts voting control, though the primary mechanism is super-voting rather than traditional dilution.
View raw filing on EDGAR →Alibaba Group Holding Ltd (BBAAY)
Alibaba completed an HK$80 billion placing of 710 million newly issued ordinary shares to non-U.S. persons at HK$112.70 per share under Regulation S, representing approximately 3.70% dilution to existing shareholders. The net proceeds of HK$79.7 billion are earmarked for AI infrastructure investment.
View raw filing on EDGAR →VISTA CREDIT STRATEGIC LENDING CORP.
Vista Credit Strategic Lending Corp. completed an unregistered sale of 104,462.348 shares of Class I common stock for $1,995,000 to accredited investors and non-U.S. persons pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D/S exemptions.
View raw filing on EDGAR →LeonaBio, Inc. (LONA)
The filing discloses the issuance of 23,031,494 Series A Common Warrants with an exercise price of $6.35 per share, which if exercised in full would provide approximately $146.2 million in capital. The warrants become exercisable upon the enrollment of the 500th subject in the ELAINE-3 Trial (triggered by this 8-K announcement), making this a material dilutive issuance. While the filing also announces a clinical trial milestone, the substantive disclosure centers on the warrant exercise mechanics and potential capital raise, characteristic of dilutive equity issuances.
View raw filing on EDGAR →Immatics N.V. (IMTX)
Immatics announced an underwritten offering of 12,945,916 ordinary shares at $8.69 per share plus pre-funded warrants to purchase 4,315,304 ordinary shares, raising $150 million in gross proceeds. This is a registered public offering of equity securities that will dilute existing shareholders, fitting the definition of a dilutive issuance. The material size ($150M) and explicit warrant structure make this a significant capital-raising event material to investors.
View raw filing on EDGAR →Founder Group Ltd (FGL)
Amendment to Pre-Paid Purchase agreement #1 originally issued July 6, 2026 ($1,080,000) modifying the share purchase price formula to 85% of the lowest VWAP over specified periods, materially altering the pricing terms for equity conversion and increasing dilution to existing shareholders.
View raw filing on EDGAR →Wetour Robotics Ltd (WETO)
Wetour Robotics entered into an at-the-market (ATM) sales agreement with Rodman & Renshaw LLC on August 26, 2026, to issue and sell ordinary shares from time to time. ATM offerings are unregistered equity issuances that are dilutive to existing shareholders and typically signal capital-raising activity at small- and mid-cap issuers. The agreement is registered under the company's Form F-3 shelf registration statement and permits sales on the Nasdaq Capital Market or other trading venues, with the sales agent receiving up to 3.0% commission.
View raw filing on EDGAR →TREASURE GLOBAL INC (TGL)
The company issued unregistered TGL Shares to Developers under Section 4(a)(2) and Regulation S exemptions, with restricted stock status and Rule 144 compliance requirements, representing a material private placement and equity dilution.
View raw filing on EDGAR →Autonomix Medical, Inc. (AMIX)
Autonomix Medical entered into a warrant inducement agreement under which it issued unregistered Series E-1 and Series E-2 warrants (collectively 1,071,826 warrant shares) to an investor in exchange for the investor's exercise of existing warrants, generating approximately $4.9 million in gross proceeds. The new warrants are exercisable at $6.25 per share with 5-year terms and were issued pursuant to Section 4(a)(2) exemption as a private placement of unregistered equity securities.
View raw filing on EDGAR →Barrel Energy Inc. (BRLL)
Barrel Energy issued a $200,000 convertible note to CFI Capital LLC, generating $173,000 in net proceeds, with conversion rights at 60% of the lowest trading price and the ability to convert up to 9.9% of outstanding shares. The company reserved 11.1 million shares for conversion and agreed to maintain a 500% reserve, signaling substantial dilution potential to existing shareholders.
View raw filing on EDGAR →FDCTECH, INC. (FDCT)
Item 3.02 discloses the conversion of 2,371,844 shares of Series B Preferred Stock into 118,592,200 shares of Common Stock on July 13, 2026, resulting in substantial dilution to existing shareholders. The conversion was effected without cash consideration and resulted in related parties (particularly Gope S. Kundnani and his affiliate Alchemy Prime Holdings Limited) receiving 99,592,200 shares, representing a material increase in their ownership proportion. This is a dilutive issuance of equity securities that would materially affect a reasonable investor's assessment of ownership and control.
View raw filing on EDGAR →Intercure Ltd. (INCR)
InterCure completed a private placement on August 25, 2026, issuing 1,579,028 units (each comprising one ordinary share and one warrant) at $2.918 per unit, raising $5 million in gross proceeds plus approximately $2 million from CEO Rabinovich. This is a classic dilutive equity issuance exempt from registration under Section 4(a)(2) and Regulation S, materially affecting shareholder ownership and capital structure.
View raw filing on EDGAR →BIOMERICA INC (BMRA)
The filing discloses a private placement of 1,393,705 shares of common stock at $1.60 per share for approximately $2.23 million in gross proceeds, closed on August 26, 2026. Item 1.01 describes entry into a Securities Purchase Agreement and Item 3.02 explicitly confirms unregistered sales of equity securities under Section 4(a)(2) and Rule 506(d). This is a classic dilutive equity issuance that would materially affect existing shareholders' ownership percentages and is a strong signal of capital-raising activity typical at small- and mid-cap issuers.
View raw filing on EDGAR →HEALTHY CHOICE WELLNESS CORP. (HCWC)
The Company established an at-the-market (ATM) equity offering program on August 26, 2026, filing a prospectus supplement and entering into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald to offer and sell up to $2,625,000 of Class A common stock. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising event for the registrant.
View raw filing on EDGAR →New Mountain Private Credit Fund
The filing discloses under Item 3.02 an unregistered sale of 5,421 common shares of beneficial interest for approximately $0.1 million at $23.06 per share, exempt under Section 4(a)(2) and Regulation D Rule 506. This is a private placement of equity securities. While the August issuance amount is modest, the filing indicates the Company is "currently offering Shares on a monthly basis" as part of a continuous private offering, signaling ongoing dilutive capital raising activity material to investors assessing ownership dilution and the fund's capital structure.
View raw filing on EDGAR →HPS Corporate Capital Solutions Fund
HPS Corporate Capital Solutions Fund issued 872,284 common shares (121,953 Class I and 750,331 Class D) for total consideration of $23.73 million on August 1, 2026, pursuant to subscription agreements and exempt from Securities Act registration under Section 4(a)(2) and Regulations D/S.
View raw filing on EDGAR →Serina Therapeutics, Inc. (SER)
Serina Therapeutics entered into a Common Stock Purchase Agreement with Roth Principal Investments granting the Company the right to sell up to $25,000,000 of newly issued common stock over 36 months at the Company's discretion, subject to a 19.99% exchange cap. The unregistered sale of common stock relies on Section 4(a)(2) and Rule 506(b) exemptions and represents a dilutive equity issuance to existing shareholders.
View raw filing on EDGAR →Gossamer Bio, Inc. (GOSS)
The filing discloses amendment of the certificate of incorporation to establish Series A-1 Convertible Preferred Stock in connection with closing of a private placement. While technically an Item 5.03 (bylaw/charter amendment), the material substance is the issuance of convertible preferred securities in a private placement, which is a dilutive capital raise. The reference to Item 1.01 of the prior 8-K (which typically covers material acquisitions and other transactions) and the explicit mention of "closing of its previously announced private placement" indicate this is a financing event, not a routine governance matter.
View raw filing on EDGAR →Black Hawk Acquisition Corp (BKHAU)
Black Hawk Acquisition Corp issued an unregistered convertible note that may be converted into shares of common stock upon closing of a DeSPAC transaction, relying on Section 4(a)(2) exemption. This dilutive issuance materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →Stonepeak-Plus Infrastructure Fund LP
Stonepeak-Plus Infrastructure Fund LP sold approximately $44.9 million in unregistered limited partnership units to third-party investors on August 3, 2026, pursuant to a continuous private offering exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Carlyle Private Equity Partners Fund, L.P.
Carlyle Private Equity Partners Fund sold approximately $13.4 million in unregistered limited partnership units to investors on August 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions, resulting in dilution to existing unitholders.
View raw filing on EDGAR →THUNDER MOUNTAIN GOLD INC (THMG)
Thunder Mountain Gold closed a non-brokered private placement on August 20, 2026, issuing 8,090,451 units (each containing one common share and one-half warrant) for US$5.66 million in gross proceeds. The securities were issued outside the United States pursuant to Regulation S as restricted securities under the Securities Act, with additional finder warrants (94,089) issued to brokers.
View raw filing on EDGAR →Swvl Holdings Corp (SWVLW)
Swvl announced a $13 million private placement (PIPE) of 8,990,317 Class A shares at $1.446 per share under Section 4(a)(2) of the Securities Act and Regulation D. This is an unregistered equity issuance that will dilute existing shareholders and raise capital for U.S. expansion and balance-sheet strengthening. The transaction is material to investors as it represents a significant capital raise and will result in Coefficient LP becoming the largest institutional shareholder with board representation.
View raw filing on EDGAR →abrdn Total Dynamic Dividend Fund (AOD)
The Fund entered into a distribution agreement authorizing the sale of up to $75 million in common shares through an at-the-market (ATM) offering, and commenced a public offering of Common Shares on August 25, 2026 pursuant to its Registration Statement.
View raw filing on EDGAR →ExchangeRight Income Fund
The filing discloses an ongoing private placement offering of up to $2.165 billion of common shares across multiple classes, with $545.065 million already raised as of July 31, 2026. This represents a substantial dilutive equity issuance. While the disclosure also mentions dividend declarations and DRIP activity, the primary material event is the continuous private offering of common shares, which is a classic dilutive issuance requiring 8-K disclosure under Item 3.02.
View raw filing on EDGAR →North Haven Private Income Fund LLC
North Haven Private Income Fund LLC completed an unregistered sale of approximately 317,050 Class S units for $5.67 million to accredited investors pursuant to subscription agreements, exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Bain Capital Private Credit
Bain Capital Private Credit sold 389,036 unregistered Class I common shares to feeder vehicles for approximately $10.1 million, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →North Haven Private Income Fund A LLC
North Haven Private Income Fund A LLC completed an unregistered sale of approximately 21,465 Class I units for $0.4 million, relying on Section 4(a)(2) and Regulation D exemptions with accredited investor representations.
View raw filing on EDGAR →LGAM Private Credit LLC
LGAM Private Credit LLC sold approximately 177,957 Common Units for $3.5 million at $19.53 per unit pursuant to subscription agreements, relying on Regulation S and other exemptions from Securities Act registration.
View raw filing on EDGAR →Apollo Infrastructure Co LLC
Apollo Infrastructure Co LLC completed an unregistered private placement of approximately $40.6 million in equity securities across multiple share classes (Series I and Series II A-II, F-I, and I Shares) to accredited and non-U.S. investors under Section 4(a)(2), Regulation D, and Regulation S.
View raw filing on EDGAR →B&R Technology Merger Corp.
B&R Technology Merger Corp. partially exercised its IPO over-allotment option, issuing 3,500,000 additional units at $10.00 per unit for $35,000,000 in gross proceeds, plus concurrent private placement units to the Sponsor. The issuance of Class A ordinary shares and warrants materially dilutes existing shareholders.
View raw filing on EDGAR →PennantPark Private Income Fund
PennantPark Private Income Fund issued 137,883 common shares for approximately $3.57 million in an unregistered private offering relying on Section 4(a)(2) and Regulation D exemptions, diluting existing shareholders' ownership.
View raw filing on EDGAR →Apollo Asset Backed Credit Co LLC
Apollo Asset Backed Credit Co LLC completed unregistered sales of equity securities totaling approximately $32.9 million across Series I and Series II share classes to third-party investors as of August 1, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions.
View raw filing on EDGAR →Grown Rogue International Inc. (GRUSF)
Grown Rogue issued unregistered equity securities to a capital partner in connection with the PharmaCann acquisition financing, including 300,000 subordinate voting shares as a commitment fee, warrants exercisable at $0.55, and up to 18.2 million shares upon conversion of a $10 million preferred equity interest at escalating prices ($0.55–$0.76), representing approximately 7% dilution at current prices with total potential dilution material to shareholders.
View raw filing on EDGAR →Caring Brands, Inc. (CABR)
Caring Brands entered into a Securities Purchase Agreement on August 21, 2026, to issue up to 11,000 shares of Series B Convertible Preferred Stock and 22,000,000 warrants in a private placement for $11 million in gross proceeds under Section 4(a)(2) and Regulation D. The transaction carries significant dilution potential with aggregate shares issuable capped at 19.99% of outstanding common stock, requiring stockholder approval to exceed this threshold.
View raw filing on EDGAR →Madison Air Solutions Corp (MAIR)
Madison Air Solutions entered into Securities Purchase Agreements to sell 90,108,130 shares of Class A common stock at $24.97 per share in a private placement generating approximately $2.25 billion in gross proceeds to accredited investors, including the controlling shareholder. The unregistered shares are issued under Section 4(a)(2) exemption and will materially dilute existing shareholders' ownership percentages and earnings per share, serving as key financing for the company's acquisition of ebm-papst entities.
View raw filing on EDGAR →Nuran Wireless Inc. (NRRWF)
NuRAN Wireless has filed a final short-form base shelf prospectus and received final regulatory approval to offer securities (common shares, debt, or other instruments) to the public, strategic investors, or through at-the-market distributions. The company explicitly states it intends to use proceeds to fund infrastructure expansion and working capital. While no specific offering has been launched yet, the shelf prospectus establishes the legal framework for future dilutive equity issuances and represents a material capital-raising event that would affect investor assessment of future ownership dilution and the company's financing strategy.
View raw filing on EDGAR →TPG Private Equity Opportunities, L.P.
TPG Private Equity Opportunities, L.P. sold $82.6 million of unregistered limited partnership units on August 1, 2026, across multiple classes (Class I, S, and F) to third-party investors and affiliates under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →AGNICO EAGLE MINES LTD (AEM)
Agnico Eagle announced a non-brokered private placement investment in Radisson Mining Resources Inc., acquiring 53,420,000 units (comprising common shares and warrants) for C$57.2 million. While this is technically an investment by Agnico Eagle in another company (Radisson), the structure involves Agnico Eagle acquiring newly-issued equity securities of Radisson in a private placement, which is dilutive to existing Radisson shareholders. The transaction is material given the size (C$57.2M) and strategic nature, and Agnico Eagle will hold ~10.45% of Radisson on a non-diluted basis and ~14.90% on a partially-diluted basis, with investor rights including board nomination and participation rights.
View raw filing on EDGAR →Nebius Group N.V. (NBIS)
Nebius Group announced the closing of a $5.75 billion private offering of convertible senior notes (0.50% due 2030 and 4.50% due 2034) to qualified institutional buyers under Rule 144A. The offering includes convertible securities that are dilutive upon conversion, and the company concurrently exchanged $800 million of existing convertible notes for approximately 15.8 million Class A ordinary shares. This is a material capital-raising transaction involving dilutive securities that would significantly affect investor assessment of share dilution and capital structure.
View raw filing on EDGAR →Fortress Private Lending Fund
Fortress Private Lending Fund sold 309,338 Class I common shares for $7.5 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →KLX Energy Services Holdings, Inc. (KLXE)
KLX Energy Services commenced a subscription rights offering on August 24, 2026, allowing eligible holders to purchase common stock at $1.49 per share. This is a dilutive equity issuance to existing shareholders and warrant holders. The company intends to use proceeds for general corporate purposes and to repurchase 2030 Notes, indicating capital-raising activity typical of financially stressed mid-cap issuers. The offering structure—transferable rights, backstop agreement with noteholders, and 9.995% ownership limitations—is characteristic of a dilutive capital raise.
View raw filing on EDGAR →Silver Point Private Credit Fund
Silver Point Private Credit Fund issued and sold 683,801 unregistered common shares for $18.38 million pursuant to subscription agreements, exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →American Healthcare REIT, Inc. (AHR)
The filing discloses a public offering of 13,250,000 shares of common stock closed on August 12, 2026, plus the full exercise of an underwriter option for an additional 1,987,500 shares, with forward sale agreements entered into on August 20, 2026. The company intends to deliver these shares upon physical settlement by August 10, 2028, in exchange for cash proceeds to fund a pending acquisition and general corporate purposes. This represents a material dilutive equity issuance that would significantly affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →Evolution Metals & Technologies Corp. (EMAT)
The disclosure centers on convertible debentures issued to Yorkville with $25.775 million aggregate principal, of which $5.775 million has been converted and $20.0 million remains outstanding. Convertible debentures are inherently dilutive securities that can result in issuance of common stock upon conversion. The filing emphasizes "future conversions of the Convertible Debentures" and "potential issuance of additional shares of common stock," signaling material dilution risk to existing shareholders. While the Item 7.01 designation and "Regulation FD Disclosure" framing suggest informational rather than transactional disclosure, the substance involves a dilutive financing arrangement material to investor assessment.
View raw filing on EDGAR →WORK Medical Technology Group LTD (WOK)
The 6-K discloses a private placement of 2,000,000 Class A ordinary shares at $1.00 per share and 50,000 Class B ordinary shares at $2.50 per share, closed on August 18, 2026, generating approximately $2.125 million in gross proceeds. The securities were issued in reliance on Section 4(a)(2) of the Securities Act and Regulation S, with no general solicitation. This is a classic unregistered equity issuance that dilutes existing shareholders and materially affects the capital structure.
View raw filing on EDGAR →StableCoinX Inc. (USDE)
StablecoinX entered into Note Consolidation and Restructuring Agreements on August 21, 2026, converting approximately $6.9 million in convertible promissory notes into warrants (Tranche A and Tranche B) exercisable for Class A common stock. Item 3.02 explicitly discloses the unregistered issuance of these warrants in reliance on Section 4(a)(2) of the Securities Act. The conversion of debt into equity warrants represents a dilutive issuance material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →